Original Research
Published on 10 Nov 2023
TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1267578
- 1,321 views
Type at least 3 characters
5,341 articles
Articles
Original Research
Published on 10 Nov 2023
A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1290968
- 1,298 views
Original Research
Published on 10 Nov 2023
Conformation-selective rather than avidity-based binding to tumor associated antigen derived peptide-MHC enables targeting of WT1-pMHC low expressing cancer cells by anti-WT1-pMHC/CD3 T cell engagers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1275304
- 1,086 views
Original Research
Published on 09 Nov 2023
Association of genes in hereditary metabolic diseases with diagnosis, prognosis, and treatment outcomes in gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1289700
- 855 views
Original Research
Published on 09 Nov 2023
Unveiling the role of hypoxic macrophage-derived exosomes in driving colorectal cancer progression
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1260638
- 995 views
Original Research
Published on 08 Nov 2023
Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1297188
- 1,382 views
Editorial
Published on 08 Nov 2023
Editorial: Interferons: key modulators of the immune system in cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1327311
- 545 views
Review
Published on 08 Nov 2023
The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1265818
- 1,000 views
Review
Published on 08 Nov 2023
Immunomodulation exerted by galectins: a land of opportunity in rare cancers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1301025
- 686 views
Original Research
Published on 07 Nov 2023
Combination of verteporfin-photodynamic therapy with 5-aza-2’-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1188087
- 927 views
Mini Review
Published on 07 Nov 2023
Recent advances in exosome-based immunotherapy applied to cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1296857
- 1,383 views
Editorial
Published on 07 Nov 2023
Editorial: Rising stars in cancer immunity and immunotherapy 2022
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1326374
- 613 views
Original Research
Published on 07 Nov 2023
Humanized single-domain antibody targeting HER2 enhances function of chimeric antigen receptor T cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1258156
- 801 views
Original Research
Published on 07 Nov 2023
Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1256491
- 2,837 views
Correction
Published on 06 Nov 2023
Corrigendum: Alveolar macrophages in lung cancer: opportunities and challenges
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1328927
- 380 views
Original Research
Published on 06 Nov 2023
Comprehensive analysis of PRPF19 immune infiltrates, DNA methylation, senescence-associated secretory phenotype and ceRNA network in bladder cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1289198
- 870 views